Mimedx (MDXG) Cash from Operations Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 34.32% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 35.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.07% |
| Dec 31, 2025 | 79.75% |
| Sep 30, 2025 | 212.72% |
| Jun 30, 2025 | 89.44% |
| Mar 31, 2025 | 36.05% |
| Dec 31, 2024 | 55.67% |
| Sep 30, 2024 | 43.47% |
| Jun 30, 2024 | 142.29% |
| Mar 31, 2024 | 42.52% |
| Dec 31, 2023 | 44.21% |
| Sep 30, 2023 | 68.33% |
| Jun 30, 2023 | 65.22% |
| Mar 31, 2023 | 30.92% |
| Dec 31, 2022 | 29.78% |
| Sep 30, 2022 | 32.07% |
| Jun 30, 2022 | -50.53% |
| Mar 31, 2022 | 12.50% |
| Dec 31, 2021 | -109.93% |
| Sep 30, 2021 | 23.06% |
| Jun 30, 2021 | -57.40% |
| Mar 31, 2021 | -38.49% |
| Dec 31, 2020 | -35.58% |
| Sep 30, 2020 | -31.18% |
| Jun 30, 2020 | -30.64% |
| Mar 31, 2020 | -46.66% |
| Dec 31, 2019 | -52.88% |
| Sep 30, 2019 | -45.98% |
| Jun 30, 2019 | -33.61% |
| Mar 31, 2019 | -149.97% |
| Dec 31, 2018 | -29.38% |
| Sep 30, 2018 | -22.54% |
| Jun 30, 2018 | 91.78% |
| Mar 31, 2018 | 34.20% |
| Dec 31, 2017 | 36.05% |
| Sep 30, 2017 | 26.12% |
| Jun 30, 2017 | 125.23% |
| Mar 31, 2017 | 104.88% |
| Dec 31, 2016 | 159.56% |
| Sep 30, 2016 | 18.06% |
| Jun 30, 2016 | 126.62% |
| Mar 31, 2016 | 22.49% |
| Dec 31, 2015 | 91.31% |
| Sep 30, 2015 | 118.80% |
| Jun 30, 2015 | 125.29% |
| Mar 31, 2015 | 74.01% |
| Dec 31, 2014 | 91.33% |
| Sep 30, 2014 | 116.96% |
| Jun 30, 2014 | 36.69% |
| Mar 31, 2014 | 3.43% |